Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertility Preservation | 7 | 2023 | 150 | 2.990 |
Why?
|
| Infertility, Female | 3 | 2023 | 217 | 1.050 |
Why?
|
| Infertility, Male | 2 | 2022 | 297 | 0.880 |
Why?
|
| Semen Preservation | 1 | 2022 | 17 | 0.860 |
Why?
|
| Directive Counseling | 1 | 2019 | 41 | 0.690 |
Why?
|
| Counseling | 1 | 2020 | 381 | 0.620 |
Why?
|
| Cryopreservation | 5 | 2022 | 175 | 0.570 |
Why?
|
| Patient Selection | 1 | 2020 | 2055 | 0.440 |
Why?
|
| Neoplasms | 3 | 2023 | 15193 | 0.310 |
Why?
|
| Oocytes | 3 | 2019 | 414 | 0.310 |
Why?
|
| Ovulation Induction | 3 | 2021 | 62 | 0.300 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2013 | 42 | 0.280 |
Why?
|
| Preimplantation Diagnosis | 2 | 2014 | 47 | 0.270 |
Why?
|
| Pregnancy, Ectopic | 1 | 2005 | 30 | 0.270 |
Why?
|
| Blastocyst | 2 | 2013 | 124 | 0.270 |
Why?
|
| Uterine Perforation | 1 | 2004 | 6 | 0.260 |
Why?
|
| Hysterosalpingography | 1 | 2004 | 15 | 0.260 |
Why?
|
| Pregnancy | 11 | 2023 | 7573 | 0.250 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 3578 | 0.230 |
Why?
|
| Chromosomes | 1 | 2004 | 244 | 0.230 |
Why?
|
| Aneuploidy | 1 | 2004 | 369 | 0.220 |
Why?
|
| Methotrexate | 1 | 2005 | 999 | 0.210 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 112 | 0.210 |
Why?
|
| Ovarian Reserve | 1 | 2021 | 10 | 0.210 |
Why?
|
| Ovarian Diseases | 1 | 2021 | 54 | 0.200 |
Why?
|
| Conservative Treatment | 1 | 2020 | 58 | 0.190 |
Why?
|
| Fertility | 1 | 2023 | 336 | 0.180 |
Why?
|
| Premenopause | 1 | 2020 | 131 | 0.180 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2020 | 1833 | 0.170 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2020 | 77 | 0.170 |
Why?
|
| Cell Nucleus | 1 | 2004 | 1620 | 0.170 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2020 | 222 | 0.170 |
Why?
|
| Female | 18 | 2023 | 141928 | 0.150 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 294 | 0.140 |
Why?
|
| Estrogens | 1 | 2020 | 751 | 0.140 |
Why?
|
| Vincristine | 1 | 2020 | 1511 | 0.140 |
Why?
|
| Endometrial Neoplasms | 2 | 2020 | 1341 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 915 | 0.120 |
Why?
|
| Humans | 19 | 2023 | 261506 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2020 | 3001 | 0.110 |
Why?
|
| Doxorubicin | 1 | 2020 | 3005 | 0.110 |
Why?
|
| BRCA2 Protein | 1 | 2014 | 358 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2014 | 493 | 0.100 |
Why?
|
| Embryo Transfer | 2 | 2013 | 83 | 0.090 |
Why?
|
| Oogenesis | 1 | 2008 | 71 | 0.080 |
Why?
|
| Granulosa Cells | 1 | 2008 | 146 | 0.080 |
Why?
|
| Adult | 11 | 2021 | 77950 | 0.080 |
Why?
|
| Obesity | 1 | 2020 | 2884 | 0.080 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2008 | 101 | 0.080 |
Why?
|
| Young Adult | 2 | 2023 | 21445 | 0.070 |
Why?
|
| Menstrual Cycle | 1 | 2005 | 56 | 0.060 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 165 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2005 | 542 | 0.060 |
Why?
|
| Blastomeres | 1 | 2004 | 24 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 4638 | 0.060 |
Why?
|
| Pregnancy Outcome | 2 | 2005 | 643 | 0.060 |
Why?
|
| Sperm Motility | 1 | 2004 | 106 | 0.060 |
Why?
|
| Live Birth | 1 | 2023 | 56 | 0.060 |
Why?
|
| Embryo Implantation | 1 | 2005 | 278 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2005 | 1391 | 0.050 |
Why?
|
| Spermatozoa | 1 | 2004 | 315 | 0.050 |
Why?
|
| Follicular Fluid | 1 | 2021 | 13 | 0.050 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2021 | 61 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 4314 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2021 | 199 | 0.050 |
Why?
|
| Wound Healing | 1 | 2004 | 815 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2004 | 2232 | 0.040 |
Why?
|
| Male | 3 | 2022 | 123000 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2019 | 37905 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 698 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 1123 | 0.040 |
Why?
|
| Endometrium | 1 | 2020 | 470 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2004 | 1225 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 5687 | 0.030 |
Why?
|
| Reproductive Behavior | 1 | 2013 | 9 | 0.030 |
Why?
|
| Biomarkers | 2 | 2020 | 5047 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2013 | 281 | 0.030 |
Why?
|
| Cytokines | 1 | 2021 | 2809 | 0.030 |
Why?
|
| United States | 2 | 2020 | 15433 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2020 | 9244 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 6100 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2004 | 8223 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 15694 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 31252 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2014 | 1589 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 17523 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 980 | 0.010 |
Why?
|
| Texas | 1 | 2013 | 6311 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 1323 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 3045 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 5539 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 15862 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 3260 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 15179 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 86204 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 70117 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 59536 | 0.000 |
Why?
|